SABR for oligometastatic renal cell carcinoma
Stereotactic ablative body radiotherapy (SABR) aims to accurately deliver a higher than conventional dose of radiotherapy to a well-defined target tumour incorporating advanced immobilisation and imaging techniques.
Chang David +8 more
doaj +3 more sources
The psychology of Sabr: toward a conceptual framework of resilience and coping for Palestinian muslims facing collective trauma [PDF]
The concept of Sabr (patient endurance) is central to Islamic spirituality yet remains significantly under-theorized in mental health research. In this Perspective, I argue that Sabr offers a culturally grounded framework for understanding resilience ...
Ibrahim Aqtam
doaj +3 more sources
A spectacular tumor response of a giant axillary mass treated with SABR in a palliative scenario
A 67-year-old male patient with a massive left axillary metastasis from an occult primary tumor (OPT) treated by stereotactic ablative radiotherapy (SABR) is presented. The patient had no clinical response to the initial chemotherapy treatment.
Fernando Kojo Matsuura +5 more
doaj +2 more sources
Background The recent phase II randomized stereotactic ablative radiotherapy with and without immunotherapy (I-SABR) trial has shown improved event-free survival (EFS) when adding immunotherapy to stereotactic ablative radiotherapy (SABR) for early-stage
Vivek Verma +21 more
doaj +2 more sources
Highlights • We describe the evolution of pelvic SABR reirradiation in the UK.• National guidance for pelvic SABR reirradiation published in full in Appendix.• Full description and examples of calculation method for cumulative dose constraints ...
E. Moreno-Olmedo +20 more
semanticscholar +2 more sources
Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease [PDF]
Stereotactic ablative radiotherapy (SABR) may extend the clinical benefit of immune checkpoint inhibitors (ICI) in patients with oligoprogressive disease. However, individual benefit varies, and validated biomarkers to guide patient selection are lacking.
Juan Zafra-Martin +14 more
doaj +2 more sources
Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre [PDF]
Simple Summary Surgery or conventional radical radiotherapy are established curative treatment options for patients with localised, stage I non-small-cell lung cancer (NSCLC).
M. Stares +14 more
semanticscholar +2 more sources
From Clinical Trials to Clinical Practice–Patterns of Practice Survey on Prostate SABR in Australia and New Zealand [PDF]
Purpose: Prostate stereotactic ablative body radiotherapy (SABR) is now a standard-of-care radiation therapy option for prostate cancer based on high-level clinical trial evidence.
Therese Kang, MBBS +16 more
doaj +2 more sources
Oncologic outcomes and renal function preservation after stereotactic ablative body radiotherapy versus radiofrequency ablation in stage I renal cell carcinoma [PDF]
Purpose: This study compared stereotactic ablative body radiotherapy (SABR) and radiofrequency ablation (RFA) in patients with biopsy-proven stage I renal cell carcinoma (RCC), focusing on oncologic outcomes and renal function outcomes. Methods: Patients
Ye Jin Yoo +5 more
doaj +2 more sources
SabR enhances nikkomycin production via regulating the transcriptional level of
Background sabR is a pleiotropic regulatory gene which has been shown to positively regulate the nikkomycin biosynthesis and negatively affect the sporulation of Streptomyces ansochromogenes.
Liu Gang +5 more
doaj +2 more sources

